In humans, several cancer types can manifest epithelial-mesenchymal transformation de novo or in response to treatment, including a subset of human IDH-wildtype glioblastomas that exhibit a mesenchymal histological subtype (i.e., gliosarcoma) and/or transcriptional profile and have been associated with worse survival (44, 45). This evidence concerns the gene IDH1 and cancer.